{"title":"NM_007294.3:c.446A\u003eC AND Breast-ovarian cancer, familial 1","submission_id":"500037.2012-07-24","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000053775","review_status":"no assertion criteria provided","variation_archive_id":"VCV000037594","date_created":"2012-11-07","version":"3","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2008-09-04","assertion_type":"variation to disease","internal_id":"89390","clinical_assertion_observation_ids":["SCV000053775.0"],"id":"SCV000053775","local_key":"SCRP_var_219","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000031175","record_status":"current","submitter_id":"500037"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Insufficient or conflicting evidence\"}"],"clinical_assertion_trait_set_id":"SCV000274232","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2016-05-27","version":"2","trait_set_id":"13598","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-05-24","assertion_type":"variation to disease","internal_id":"510686","clinical_assertion_observation_ids":["SCV000274232.0"],"id":"SCV000274232","local_key":"a31329","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000219296","record_status":"current","submitter_id":"61756"}
{"submission_id":"500105.2018-11-14","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000895101","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"practice guideline\",\"ID\":[{\"$\":\"25741868\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2015.30\",\"@Source\":\"DOI\"}]}}","date_created":"2019-03-28","version":"1","submission_names":["SUB4786732"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-10-31","assertion_type":"variation to disease","internal_id":"1751540","clinical_assertion_observation_ids":["SCV000895101.0"],"id":"SCV000895101","local_key":":Chr.17_41251893_41251893_T_G|OMIM:114480;604370;614320;617883","interpretation_description":"Uncertain significance","variation_id":"37594","record_status":"current","submitter_id":"500105"}
{"submission_id":"505849.2018-11-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000910906","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2019-05-17","version":"1","trait_set_id":"13598","submission_names":["SUB4721021"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-04-19","assertion_type":"variation to disease","internal_id":"1778861","clinical_assertion_observation_ids":["SCV000910906.0"],"id":"SCV000910906","local_key":"Db4KrQBSZeoE7-orUyypkaRSy9Lm52xvIWbvYpjplzM|MedGen:C0027672","interpretation_description":"Likely benign","variation_id":"37594","rcv_accession_id":"RCV000219296","record_status":"current","submitter_id":"505849"}
{"submission_id":"500031.2019-03-28","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces glutamic acid with alanine at codon 149 of the BRCA1 protein (p.Glu149Ala). The glutamic acid residue is moderately conserved and there is a moderate physicochemical difference between glutamic acid and alanine. This variant is present in population databases (rs397507233, ExAC 0.07%). This variant has been reported in individuals affected with breast cancer (PMID: 22116506, 27257965) and stomach cancer (PMID: 26689913). ClinVar contains an entry for this variant (Variation ID: 37594). Experimental studies have shown that this missense change does not impact BRCA1 homology-directed repair activity (PMID: 26689913). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.\"}"],"clinical_assertion_trait_set_id":"SCV000549301","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26689913\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22116506\",\"@Source\":\"PubMed\"}}]}}","date_created":"2017-04-13","version":"5","trait_set_id":"7920","submission_names":["SUB5371970"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-12-19","assertion_type":"variation to disease","internal_id":"1062197","clinical_assertion_observation_ids":["SCV000549301.0"],"id":"SCV000549301","local_key":"676082|MedGen:C0677776","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000458634","record_status":"current","submitter_id":"500031"}
{"submission_id":"26957.2019-01-29","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is denoted BRCA1 c.446A\u003eC at the cDNA level, p.Glu149Ala (E149A) at the protein level, and results in the change of a Glutamic Acid to an Alanine (GAA\u003eGCA). Using alternate nomenclature, this variant would be defined as BRCA1 565A\u003eC. This variant was observed in several individuals with breast cancer and in one individual with gastric cancer (Zhang 2012, Lu 2015, Zhong 2016, Wei 2018). Functional analysis of this variant showed no significant difference as compared to wild type in a homologous directed repair assay (Lu 2015). BRCA1 Glu149Ala was observed at an allele frequency of 0.06% (12/18870) in individuals of East Asian ancestry in large population cohorts (Lek 2016). This variant is located within a region that binds BRD7 (Harte 2010). Protein-based in silico analysis, which includes protein predictors and evolutionary conservation, predicts that this variant is probably damaging to protein structure and function, and splicing models are uninformative in their assessment as to whether or not the variant is damaging. Based on currently available evidence, it is unclear whether BRCA1 Glu149Ala is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.\"}"],"clinical_assertion_trait_set_id":"SCV000570422","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2017-04-24","version":"5","trait_set_id":"9460","submission_names":["SUB5098196"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-09-25","assertion_type":"variation to disease","internal_id":"1105529","clinical_assertion_observation_ids":["SCV000570422.0"],"id":"SCV000570422","local_key":"GDX:1080047|Not Provided","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000479398","record_status":"current","submitter_id":"26957"}
{"submission_id":"505720.2016-02-27","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000265873","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}}}","date_created":"2016-03-15","version":"1","submission_names":["Chinese507BC_BRCA"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-01","assertion_type":"variation to disease","internal_id":"498108","clinical_assertion_observation_ids":["SCV000265873.0"],"id":"SCV000265873","local_key":"NM_007294.3:c.446A\u003eC|MedGen:CN221572","interpretation_description":"Uncertain significance","variation_id":"37594","record_status":"current","submitter_id":"505720"}
{"submission_id":"506039.2018-11-26","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000883121","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2019-02-15","version":"1","trait_set_id":"6265","submission_names":["SUB4842992"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-11-21","assertion_type":"variation to disease","internal_id":"1729239","clinical_assertion_observation_ids":["SCV000883121.0"],"id":"SCV000883121","local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"506039"}
{"submission_id":"25969.2018-10-10","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The APC c.3920T\u003eA; p.Ile1307Lys variant has been reported extensively in the literature. One recent meta-analysis of 30 published population studies, all of which examined the association between p.Ile1307Lys and colorectal neoplasia, colorectal adenoma, and/or colorectal cancer, concluded that this variant confers a two-fold increased risk of developing a colorectal neoplasia to persons of Ashkenazi Jewish ancestry (Liang 2013 and references therein). However, the c.3920T\u003eA;p.Ile1307Lys variant is observed in the general population at an overall frequency of 0.18% (506/276756 alleles, 6 homozygotes) in the Genome Aggregation Database. Due to the high frequency in the general population, this variant is considered likely benign. REFERENCES Liang et al. APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol. 2013;177(11):1169-1179.\"}"],"clinical_assertion_trait_set_id":"SCV000602533","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","date_created":"2017-09-27","version":"2","trait_set_id":"9460","submission_names":["SUB4618058"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-06-20","assertion_type":"variation to disease","internal_id":"1166229","clinical_assertion_observation_ids":["SCV000602533.0"],"id":"SCV000602533","local_key":"11931|Not Provided","interpretation_description":"Likely benign","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"25969"}
{"submission_id":"500110.2020-03-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000600091","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29478780\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14633595\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16875934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29506128\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29961768\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30152102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30487145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12533824\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135136\",\"@Source\":\"PubMed\"}}]}}","date_created":"2017-09-27","version":"2","trait_set_id":"9460","submission_names":["SUB6975398"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-08-04","assertion_type":"variation to disease","internal_id":"1163765","clinical_assertion_observation_ids":["SCV000600091.0"],"id":"SCV000600091","local_key":"2564206|not provided","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"500110"}
{"submission_id":"505698.2017-10-05","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000610138","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-11-02","version":"1","trait_set_id":"9460","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-07-27","assertion_type":"variation to disease","internal_id":"1190191","clinical_assertion_observation_ids":["SCV000610138.0"],"id":"SCV000610138","local_key":"19388615","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"505698"}
{"submission_id":"26957.2018-09-07","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is denoted APC c.3920T\u003eA at the DNA level and p.Ile1307Lys (I1307K) at the protein level, replacing an Isoleucine with a Lysine. APC Ile1307Lys is a common variant, observed at an allele frequency of 3.7% (371/10,138) in individuals of Ashkenazi Jewish ancestry in large population cohorts (Lek 2016) and in up to 11% of individuals in Ashkenazi Jewish cohorts in the literature (Liang 2013, Boursi 2013). A meta-analysis of epidemiologic studies of APC polymorphisms suggests that individuals of Ashkenazi Jewish ancestry who carry this variant have a 2-fold increased risk of colorectal cancer (Liang 2013). However, studies of this variant in other populations did not report an increased risk of colorectal cancer (Liang 2013); therefore, the clinical significance in individuals without Jewish ancestry is not clear at this time. In sum, we consider APC Ile1307Lys to be a risk allele. The National Comprehensive Cancer Network has management guidelines for individuals carrying the APC Ile1307Lys risk allele (NCCN).\"}"],"clinical_assertion_trait_set_id":"SCV000148996","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification(06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2014-05-13","version":"4","trait_set_id":"9460","submission_names":["SUB4498316"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-05-08","assertion_type":"variation to disease","internal_id":"269650","clinical_assertion_observation_ids":["SCV000148996.0"],"id":"SCV000148996","local_key":"GDX:3786|Not Provided","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"26957"}
{"submission_id":"500031.2019-03-28","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces isoleucine with lysine at codon 1307 of the APC protein (p.Ile1307Lys). The isoleucine residue is weakly conserved and there is a moderate physicochemical difference between isoleucine and lysine. This variant is present in population databases (rs1801155, ExAC 0.3%). This variant is found in ~10% of Ashkenazi Jewish individuals and ~3% of Sephardic Jewish individuals (PMID: 23896379). Other studies have reported a 6-7% frequency in Ashkenazi individuals (PMID: 9288102). This variant is found in ~28% of Ashkenazi Jewish individuals with familial colorectal cancer (PMID: 9288102). ClinVar contains an entry for this variant (Variation ID: 822). In a large meta-analysis involving ~10,000 cases and controls (PMID: 23576677), Ashkenazi Jewish individuals who carried the I1307K change had a significantly increased risk of colorectal cancer (OR=2.17, 95% CI=1.65-2.86). By contrast, the I1307K change did not appear to confer any additional risk of colorectal cancer in non-Ashkenazi Jewish individuals (OR=1.36, 95% CI=0.59-3.13). This DNA substitution converts an AAATAAAA sequence element into an extended tract of eight adenosine nucleotides (A8). The A8 mononucleotide tract created by this change has been shown to confer an increased propensity for somatic truncating mutations on this allele (PMID: 9751605). In summary, this is a frequently observed variant that is associated with a 2-fold increased risk of colorectal cancer in the Ashkenazi Jewish population. An increased risk of colorectal cancer in individuals who are not of Ashkenazi Jewish ancestry has not been established.\"}"],"clinical_assertion_trait_set_id":"SCV000153895","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-06-03","version":"9","trait_set_id":"6265","submission_names":["SUB5371970"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-01-14","assertion_type":"variation to disease","internal_id":"279290","clinical_assertion_observation_ids":["SCV000153895.0"],"id":"SCV000153895","local_key":"7840|MedGen:C2713442","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"500031"}
{"submission_id":"504914.2014-05-29","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000084184","review_status":"no assertion provided","variation_archive_id":"VCV000000822","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},\"Comment\":{\"$\":\"Please see associated publication for description of ethnicities\"}}","date_created":"2014-06-09","version":"1","trait_set_id":"9590","submission_names":["Cancer_genes_01"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2013-09-19","assertion_type":"variation to disease","internal_id":"281153","clinical_assertion_observation_ids":["SCV000084184.0","SCV000084184.1","SCV000084184.2","SCV000084184.3","SCV000084184.4","SCV000084184.5","SCV000084184.6"],"id":"SCV000084184","local_key":"MedGen:CN169374","interpretation_description":"not provided","variation_id":"822","rcv_accession_id":"RCV000120049","record_status":"current","submitter_id":"504914"}
{"submission_id":"165021.2016-01-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000297021","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"DGD Variant Analysis Guidelines\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"DGD_Variant_Analysis_Guidelines.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx\"}}},\"StudyDescription\":{\"$\":\"Clinical exome data\"}}","date_created":"2016-07-29","version":"2","trait_set_id":"8942","submission_names":["exome2015-12-22"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-24","assertion_type":"variation to disease","internal_id":"574598","clinical_assertion_observation_ids":["SCV000297021.0"],"id":"SCV000297021","local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0032580","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000238802","record_status":"current","submitter_id":"165021"}
{"submission_id":"505870.2019-07-12","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV001154466","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","date_created":"2020-01-31","version":"1","trait_set_id":"9460","submission_names":["2019-07"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-05-01","assertion_type":"variation to disease","internal_id":"2272833","clinical_assertion_observation_ids":["SCV001154466.0"],"id":"SCV001154466","local_key":":Chr.5_112175211_112175211_T_A|MedGen:CN517202","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"505870"}
{"submission_id":"239772.2018-01-29","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000805404","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-09-12","version":"1","trait_set_id":"9460","submission_names":["SUB3589995"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-01-06","assertion_type":"variation to disease","internal_id":"1570355","clinical_assertion_observation_ids":["SCV000805404.0"],"id":"SCV000805404","local_key":"NM_000038.5:c.3920T\u003eA|not provided","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"239772"}
{"submission_id":"320494.2017-06-22","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"I1307K is associated with a 10-20% lifetime risk of developing colon cancer in individuals of Ashkenazi Jewish ancestry and is not known to cause classic or attenuated FAP.\"}"],"clinical_assertion_trait_set_id":"SCV000677724","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_%25282015%2529_v1.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17854661\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15712637\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-01-04","version":"1","trait_set_id":"6265","submission_names":["SUB2805501"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-09-27","assertion_type":"variation to disease","internal_id":"1328882","clinical_assertion_observation_ids":["SCV000677724.0"],"id":"SCV000677724","local_key":"76464|OMIM:175100","interpretation_description":"Likely pathogenic","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"320494"}
{"submission_id":"1024.2018-07-17","submitted_assembly":"GRCh38","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000807826","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-09-20","version":"1","trait_set_id":"35108","submission_names":["SUB4304907"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-06-01","assertion_type":"variation to disease","internal_id":"1575248","clinical_assertion_observation_ids":["SCV000807826.0"],"id":"SCV000807826","local_key":"APC-B1|MedGen:CN240755","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000680453","record_status":"current","submitter_id":"1024"}
{"submission_id":"500035.2018-11-11","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000838110","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","date_created":"2018-10-05","version":"2","trait_set_id":"6265","submission_names":["MENDELICS_CLINVAR_015"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-07-02","assertion_type":"variation to disease","internal_id":"1610680","clinical_assertion_observation_ids":["SCV000838110.0"],"id":"SCV000838110","local_key":"NC_000005.9:g.112175211T\u003eA|MedGen:C2713442","interpretation_description":"Likely pathogenic","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"500035"}
{"submission_id":"505504.2018-08-08","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000821694","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-10-05","version":"1","trait_set_id":"13598","submission_names":["SUB4381212"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-08-01","assertion_type":"variation to disease","internal_id":"1609757","clinical_assertion_observation_ids":["SCV000821694.0"],"id":"SCV000821694","local_key":"NM_000038.5:c.3920T\u003eA|MedGen:C0027672","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000115087","record_status":"current","submitter_id":"505504"}
{"title":"APC, ILE1307LYS_BREAST CANCER, SUSCEPTIBILITY TO","submission_id":"3.2010-12-30","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000021015","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","date_created":"2011-01-25","version":"3","trait_set_id":"216","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2003-12-01","assertion_type":"variation to included disease","internal_id":"21015","clinical_assertion_observation_ids":["SCV000021015.0"],"id":"SCV000021015","local_key":"611731.0029_BREAST CANCER, SUSCEPTIBILITY TO","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000000865","record_status":"current","submitter_id":"3"}
{"title":"APC, ILE1307LYS_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","submission_id":"3.2014-02-19","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000021014","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","date_created":"2011-01-25","version":"3","trait_set_id":"215","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-04-01","assertion_type":"variation to disease","internal_id":"21014","clinical_assertion_observation_ids":["SCV000021014.0"],"id":"SCV000021014","local_key":"611731.0029_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000000864","record_status":"current","submitter_id":"3"}
{"submission_id":"500199.2018-06-14","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The c.3920T\u003eA (p.Ile1307Lys) variant in the APC gene has been reported as a common risk allele associated with familial colorectal cancer in the Ashkenazi Jewish population [PMID 18770064, 24416237]. The c.3920T\u003eA variant has been reported to result in an adenine replacing a thymine and creating an oligo-adenine (A8) tract that appears to be inherently prone to further somatic mis-pairing and slippage during DNA replication, thereby creating a frameshift change [PMID 9288102, 18770064 and 244162370]. However, this variant has also been reported at a high frequency, present in 6% of Ashkenazi Jews and about 28% of Ashkenazim with a family history of colorectal cancer [PMID: 9288102]. Isoleucine at amino acid position 1307 of the APC protein is weakly conserved during evolution. While not validated for clinical use, the SIFT and PolyPhen-2 algorithms predict this variant to be benign. Ashkenazi Jews who carry the p.Ile1307Lys variant are at increased risk for colorectal neoplasia: the risk for colorectal neoplasia in heterozygous Ashkenazi Jewish individuals was estimated to be between 1.7 to 2.17 compared to non carrier individuals [PMID 12173321, 23576677, 23896379]. This variant is classified as as a risk allele with an increased risk for colorectal neoplasia in the Ashkenazi Jewish population. However the risk in non Jewish populations has not been determined.\"}"],"clinical_assertion_trait_set_id":"SCV000839876","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-10-11","version":"1","trait_set_id":"6265","submission_names":["SUB4151980"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-06-02","assertion_type":"variation to disease","internal_id":"1637429","clinical_assertion_observation_ids":["SCV000839876.0"],"id":"SCV000839876","local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"500199"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Significant disease association in appropriately sized case-control study(ies);Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation;Other strong data supporting pathogenic classification\"}"],"clinical_assertion_trait_set_id":"SCV000183892","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16228836\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-08-01","version":"7","trait_set_id":"13598","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-02-28","assertion_type":"variation to disease","internal_id":"302407","clinical_assertion_observation_ids":["SCV000183892.0"],"id":"SCV000183892","local_key":"a4793","interpretation_description":"Pathogenic","variation_id":"822","rcv_accession_id":"RCV000115087","record_status":"current","submitter_id":"61756"}
{"submission_id":"505849.2018-11-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000686956","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-02-16","version":"2","trait_set_id":"13598","submission_names":["SUB4721021"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-05-21","assertion_type":"variation to disease","internal_id":"1344252","clinical_assertion_observation_ids":["SCV000686956.0"],"id":"SCV000686956","local_key":"Db4KrQBSZeoE7-orUyypkal4dklV7Tc_lQTp9W4PGUo|MedGen:C0027672","interpretation_description":"Likely pathogenic","variation_id":"822","rcv_accession_id":"RCV000115087","record_status":"current","submitter_id":"505849"}
{"submission_id":"1160.2012-07-15","interpretation_comments":["{\"text\":\"Converted during submission to Uncertain significance.\"}"],"clinical_assertion_trait_set_id":"SCV000043125","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},\"StudyName\":{\"$\":\"ClinSeq\"}}","date_created":"2013-03-26","version":"1","trait_set_id":"9460","submission_names":["ClinSeq_cancer"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2012-07-13","assertion_type":"variation to disease","internal_id":"98286","clinical_assertion_observation_ids":["SCV000043125.0"],"id":"SCV000043125","local_key":"NM_000038.4:c.3920T\u003eA|not provided","interpretation_description":"variant of unknown significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"1160"}
{"submission_id":"506273.2017-11-15","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000693480","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","date_created":"2018-03-01","version":"1","trait_set_id":"13598","submission_names":["SUB3222006"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-11-10","assertion_type":"variation to disease","internal_id":"1359177","clinical_assertion_observation_ids":["SCV000693480.0"],"id":"SCV000693480","local_key":"CCDS4107.1:c.3920T\u003eA|Hereditary cancer-predisposing syndrome","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000115087","record_status":"current","submitter_id":"506273"}
{"submission_id":"506211.2018-10-29","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000853088","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-11-21","version":"1","trait_set_id":"1735","submission_names":["SUB4705375"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-01-01","assertion_type":"variation to disease","internal_id":"1663716","clinical_assertion_observation_ids":["SCV000853088.0"],"id":"SCV000853088","local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0699790","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000722046","record_status":"current","submitter_id":"506211"}
{"submission_id":"500026.2019-09-24","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant summary: APC c.3920T\u003eA (p.Ile1307Lys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 251040 control chromosomes in the gnomAD database (exomes dataset), predominantly found within the Ashkenazi Jewish subpopulation at a frequency of 0.036, including 7 homozygotes. The observed variant frequency within Ashkenazi Jewish control individuals in the gnomAD database is approximately 500 fold of the estimated maximal expected allele frequency for a pathogenic variant in APC causing Familial Adenomatous Polyposis (FAP) phenotype (7.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Ashkenazi Jewish origin. The variant, c.3920T\u003eA, has been reported in the literature in multiple individuals affected with colorectal cancer (CRC) and other tumor phenotypes, however in some of these cases it was also reported to co-occur with other pathogenic variants (Yurgelun_2017 and Simbolo_2015). Multiple case-control studies (Abdel-Malak_2016, Drucker_2000, Fidder_2005, Gryfe_1998, Laken_1997, Leshno_2016, and Shtoyerman-Chen_2001), demonstrated that this variant is associated with a moderately increased risk for CRC in Ashkenazi Jewish population. A large meta-analysis concluded that the variant increases the risk about two-fold for CRC in individuals of Ashkenazi Jewish ancestry (OR=2.17, 95% CI=1.65-2.86), however it does not appear to confer an additional risk for CRC in non-Ashkenazi cases (Liang_2013). A recent case-control study involving a large Israeli cohort indicated that this variant might be also associated with a significantly higher risk for non-CRC cancers, with the APC I1307K variant being proposed as a reliable marker for overall cancer risk (OR=2.53) (Leshno_2016). The A8 mononucleotide tract created by this germline change has been shown to confer an increased propensity for generating somatic frameshift mutations on this allele, leading to a loss of function of APC that constitutes an important somatic event in tumor initiation (Gryfe_1998; Laken_1997). 19 other submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments, with 7 reporting it as a risk factor. Taken together, this polymorphic variant is associated with a modestly increased risk for CRC in the Ashkenazi Jewish population, but is not associated with FAP or AFAP. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000694042","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26300997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26394139\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27978560\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14633595\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28050010\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25604157\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10679643\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15929773\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11207040\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28749474\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30152102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30426508\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26187149\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29961768\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-03-15","version":"2","trait_set_id":"9590","submission_names":["SUB6341163"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-08-27","assertion_type":"variation to disease","internal_id":"1360394","clinical_assertion_observation_ids":["SCV000694042.0"],"id":"SCV000694042","local_key":"NM_000038.5:c.3920T\u003eA|MedGen:CN169374","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000120049","record_status":"current","submitter_id":"500026"}
{"submission_id":"506834.2016-03-03","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Low penetrance mutation that is associated with a small increase in risk of colon cancer and with an increased risk of colon polyps (Boursi 2013)\"}"],"clinical_assertion_trait_set_id":"SCV000266006","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Shirts et al. (Genet Med 2016)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2016-03-19","version":"1","trait_set_id":"1570","submission_names":["GIM_BROCA"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-20","assertion_type":"variation to disease","internal_id":"498299","clinical_assertion_observation_ids":["SCV000266006.0","SCV000266006.1","SCV000266006.2","SCV000266006.3","SCV000266006.4","SCV000266006.5","SCV000266006.6","SCV000266006.7","SCV000266006.8"],"id":"SCV000266006","local_key":"c.3920T\u003eA","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000210085","record_status":"current","submitter_id":"506834"}
{"submission_id":"506152.2017-04-19","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000591159","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16140997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19047896\",\"@Source\":\"PubMed\"}}]},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-25","version":"1","trait_set_id":"9590","submission_names":["SHS20170111"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-08-15","assertion_type":"variation to disease","internal_id":"1147603","clinical_assertion_observation_ids":["SCV000591159.0"],"id":"SCV000591159","local_key":"NM_000038.5:c.3920T\u003eA|not specified","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000120049","record_status":"current","submitter_id":"506152"}
{"title":"NM_000038.3:c.3920T\u003eA and APC-Associated Polyposis Conditions","submission_id":"500062.2013-01-08","interpretation_comments":["{\"text\":\"Converted during submission to Pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000040392","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","date_created":"2011-05-06","version":"1","trait_set_id":"6265","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2011-10-27","assertion_type":"variation to disease","internal_id":"40392","clinical_assertion_observation_ids":["SCV000040392.0"],"id":"SCV000040392","local_key":"NM_000038.3:c.3920T\u003eA_NBK1345","interpretation_description":"pathologic","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"500062"}
{"submission_id":"500031.2019-03-28","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change creates a premature translational stop signal (p.Asn1355Lysfs*10) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs80357508, ExAC 0.006%). This variant has been reported in multiple individuals and families affected with breast and ovarian cancer (PMID: 14757871, 8571953, 11802209, 21559243). This variant is also known as 4184del4 in the literature. ClinVar contains an entry for this variant (Variation ID: 17674). Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000076444","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}}]}}","date_created":"2013-07-02","version":"11","trait_set_id":"7920","submission_names":["SUB5371970"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-01-09","assertion_type":"variation to disease","internal_id":"124374","clinical_assertion_observation_ids":["SCV000076444.0"],"id":"SCV000076444","local_key":"306942|MedGen:C0677776","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"500031"}
{"submission_id":"504196.2014-03-28","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000144954","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","date_created":"2014-03-30","version":"2","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2002-05-29","assertion_type":"variation to disease","internal_id":"261852","clinical_assertion_observation_ids":["SCV000144954.0","SCV000144954.1","SCV000144954.2","SCV000144954.3","SCV000144954.4","SCV000144954.5","SCV000144954.6","SCV000144954.7","SCV000144954.8","SCV000144954.9","SCV000144954.10","SCV000144954.11","SCV000144954.12","SCV000144954.13","SCV000144954.14","SCV000144954.15","SCV000144954.16","SCV000144954.17","SCV000144954.18","SCV000144954.19","SCV000144954.20","SCV000144954.21","SCV000144954.22","SCV000144954.23","SCV000144954.24","SCV000144954.25"],"id":"SCV000144954","local_key":"U14680.1:n.4184_4187delTCAA|MedGen:C2676676","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"504196"}
{"title":"NM_007294.3:c.4065_4068delTCAA AND Breast-ovarian cancer, familial 1","submission_id":"500037.2015-12-29","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000053742","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","date_created":"2012-11-07","version":"6","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2013-03-21","assertion_type":"variation to disease","internal_id":"89357","clinical_assertion_observation_ids":["SCV000053742.0"],"id":"SCV000053742","local_key":"SCRP_var_186","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"500037"}
{"submission_id":"504863.2016-06-09","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant allele predicted to encode a truncated non-functional protein.\"}"],"clinical_assertion_trait_set_id":"SCV000282322","review_status":"reviewed by expert panel","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ENIGMA BRCA1/2 Classification Criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ENIGMA BRCA1/2 Classification Criteria (2015)\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf\"}}},\"StudyDescription\":{\"$\":\"ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/\"}}","date_created":"2016-06-24","version":"1","trait_set_id":"1917","submission_names":["ENIGMA_2015-08-17"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-04-22","assertion_type":"variation to disease","internal_id":"537053","clinical_assertion_observation_ids":["SCV000282322.0"],"id":"SCV000282322","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"504863"}
{"submission_id":"26957.2019-01-29","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This deletion of four nucleotides in BRCA1 is denoted c.4065_4068delTCAA at the cDNA level and p.Asn1355LysfsX10 (N1355KfsX10) at the protein level. The normal sequence, with the bases that are deleted in brackets, is ATAA[delTCAA]GAAG. The deletion causes a frameshift, which changes an Asparagine to a Lysine at codon 1355, and creates a premature stop codon at position 10 of the new reading frame. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant, also reported as BRCA1 4184del4 or 4184_4187delTCAA using alternate nomenclature, has been reported in association with hereditary breast cancer and in multiple individuals with breast, ovarian, or prostate cancer (Friedman 1994, Neuhausen 1996, Liede 2002, Meindl 2002, Farooq 2011, Couch 2015, Bu 2016, Chan 2018). We consider this variant to be pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000210049","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2015-02-19","version":"13","trait_set_id":"9460","submission_names":["SUB5098196"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-12-19","assertion_type":"variation to disease","internal_id":"375724","clinical_assertion_observation_ids":["SCV000210049.0"],"id":"SCV000210049","local_key":"GDX:7571|Not Provided","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000159924","record_status":"current","submitter_id":"26957"}
{"submission_id":"500110.2020-03-06","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one symptomatic patient, and found in general population data that is consistent with pathogenicity.\"}"],"clinical_assertion_trait_set_id":"SCV000296305","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"26295337\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23633455\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23519070\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20104584\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"7894493\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23175448\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29339979\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29752822\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28831036\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25085752\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27553291\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29470806\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28724667\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21324516\",\"@Source\":\"PubMed\"}}]}}","date_created":"2016-07-29","version":"4","trait_set_id":"9460","submission_names":["SUB6975398"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-03-20","assertion_type":"variation to disease","internal_id":"573876","clinical_assertion_observation_ids":["SCV000296305.0"],"id":"SCV000296305","local_key":"2420169|not provided","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000159924","record_status":"current","submitter_id":"500110"}
{"submission_id":"505504.2016-07-19","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000296801","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2016-07-29","version":"1","trait_set_id":"9590","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-07-01","assertion_type":"variation to disease","internal_id":"574372","clinical_assertion_observation_ids":["SCV000296801.0"],"id":"SCV000296801","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN169374","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000238776","record_status":"current","submitter_id":"505504"}
{"submission_id":"1006.2017-02-23","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000540939","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"StudyDescription\":{\"$\":\"Variants for BRCA1/2 tests\"}}","date_created":"2017-04-13","version":"1","trait_set_id":"774","submission_names":["BRCA12"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-02-23","assertion_type":"variation to disease","internal_id":"1053858","clinical_assertion_observation_ids":["SCV000540939.0"],"id":"SCV000540939","local_key":"NM_007294.3:c.4065_4068delTCAA|Familial cancer of breast","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000476410","record_status":"current","submitter_id":"1006"}
{"submission_id":"505260.2017-04-17","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000564378","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-04-21","version":"1","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-20","assertion_type":"variation to disease","internal_id":"1099012","clinical_assertion_observation_ids":["SCV000564378.0"],"id":"SCV000564378","local_key":"NM_007294.3:c.4065_4068del|MedGen:C2676676","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"505260"}
{"submission_id":"1050.2017-08-28","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000219238","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2015-03-28","version":"3","trait_set_id":"7920","submission_names":["CHEO20170828_update"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-02-01","assertion_type":"variation to disease","internal_id":"395994","clinical_assertion_observation_ids":["SCV000219238.0"],"id":"SCV000219238","local_key":"1776816|Orphanet:ORPHA145","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"1050"}
{"submission_id":"320494.2015-03-11","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000220878","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_(2015)_v1.pdf\"}}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23683081\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24549055\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23633455\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17018160\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21324516\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"7894493\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24556621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23175448\",\"@Source\":\"PubMed\"}}]}}","date_created":"2015-03-28","version":"1","trait_set_id":"1917","submission_names":["Counsyl_2015_03_01"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2014-11-14","assertion_type":"variation to disease","internal_id":"397634","clinical_assertion_observation_ids":["SCV000220878.0"],"id":"SCV000220878","local_key":"NM_007294.3(BRCA1):c.4065_4068delTCAA","interpretation_description":"Likely pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"320494"}
{"submission_id":"500035.2018-08-20","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000839242","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","date_created":"2018-10-05","version":"1","trait_set_id":"7920","submission_names":["SUB4427121"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-07-02","assertion_type":"variation to disease","internal_id":"1611812","clinical_assertion_observation_ids":["SCV000839242.0"],"id":"SCV000839242","local_key":"NC_000017.10:g.41243480_41243483delTTGA|MedGen:C0677776","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"500035"}
{"title":"BRCA1, 4-BP DEL, 4185TCAA_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","submission_id":"3.2010-12-30","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000039531","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","date_created":"2011-01-25","version":"4","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"1994-12-01","assertion_type":"variation to disease","internal_id":"39531","clinical_assertion_observation_ids":["SCV000039531.0"],"id":"SCV000039531","local_key":"113705.0015_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"3"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)\"}"],"clinical_assertion_trait_set_id":"SCV000186942","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"28831036\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24556621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30825404\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16455195\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29752822\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28724667\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29339979\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29470806\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24504028\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28993434\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27553291\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10699917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30078507\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-08-01","version":"5","trait_set_id":"13598","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-03-26","assertion_type":"variation to disease","internal_id":"305457","clinical_assertion_observation_ids":["SCV000186942.0"],"id":"SCV000186942","local_key":"a89762","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000131887","record_status":"current","submitter_id":"61756"}
{"submission_id":"505214.2017-03-15","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000577930","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-05-25","version":"1","trait_set_id":"1917","submission_names":["BRCA_Malaga"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-01-01","assertion_type":"variation to disease","internal_id":"1125848","clinical_assertion_observation_ids":["SCV000577930.0"],"id":"SCV000577930","local_key":"GNL0017|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"505214"}
{"submission_id":"505849.2017-10-26","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000683147","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-02-15","version":"1","trait_set_id":"13598","submission_names":["SUB3163908"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-04-13","assertion_type":"variation to disease","internal_id":"1338690","clinical_assertion_observation_ids":["SCV000683147.0"],"id":"SCV000683147","local_key":"Db4KrQBSZeoE7-orUyypkQ9ffftxzNCEBpQllhdTwYY|MedGen:C0027672","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000131887","record_status":"current","submitter_id":"505849"}
{"submission_id":"500026.2018-01-25","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant summary: The BRCA1 c.4065_4068delTCAA (p.Asn1355Lysfs) variant results in a premature termination codon, predicted to cause a truncated or absent BRCA1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.4117G\u003eT, p.Glu1373X; c.4158_4162delCTCTC, p.Ser1387fs). This variant has been reported in numerous HBOC patients with positive family history (e.g. Langston 1996, Spitzer 2000, Evans 2004, Borg 2010). This variant is absent in 121322 control chromosomes, suggesting that it is not a common, benign variant. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000699105","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20104584\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10699917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21702907\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-03-15","version":"1","trait_set_id":"7920","submission_names":["2016-2017-variants"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-08-22","assertion_type":"variation to disease","internal_id":"1365457","clinical_assertion_observation_ids":["SCV000699105.0"],"id":"SCV000699105","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:C0677776","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"500026"}
{"submission_id":"505954.2016-10-28","submitted_assembly":"hg18","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000325829","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"CIMBA Mutation Classification guidelines May 2016\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"CIMBA_Mutation_Classification_guidelines_May16.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/MIHuUwlX/CIMBA_Mutation_Classification_guidelines_May16.pdf\"}}}}","date_created":"2016-11-04","version":"3","trait_set_id":"1917","submission_names":["CIMBA_20161005"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-10-02","assertion_type":"variation to disease","internal_id":"624937","clinical_assertion_observation_ids":["SCV000325829.0"],"id":"SCV000325829","local_key":"NM_007294.3:c.4065_4068del|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"505954"}
{"submission_id":"506382.2018-04-04","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000733615","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","content":"{\"StudyName\":{\"$\":\"VKGL Data-share Consensus\"}}","date_created":"2018-04-06","version":"1","trait_set_id":"1917","submission_names":["SUB3868021"],"date_last_updated":"2020-03-26","assertion_type":"variation to disease","internal_id":"1414776","clinical_assertion_observation_ids":["SCV000733615.0"],"id":"SCV000733615","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"506382"}
{"title":"SUB2892902","submission_id":"505785.2017-07-24","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000584013","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"12402332\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"12698193\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"9649133\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"3405339\",\"@Source\":\"pmc\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"9150148\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"3893336\",\"@Source\":\"pmc\"}}]}","date_created":"2017-07-26","version":"1","trait_set_id":"1917","submission_names":["SUB2892902"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-07-21","assertion_type":"variation to disease","internal_id":"1139118","clinical_assertion_observation_ids":["SCV000584013.0"],"id":"SCV000584013","local_key":"SUB2892902","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"505785"}
{"submission_id":"500086.2018-07-18","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000863590","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2018-12-20","version":"1","trait_set_id":"20192","submission_names":["SUB4310295"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2010-07-08","assertion_type":"variation to disease","internal_id":"1688796","clinical_assertion_observation_ids":["SCV000863590.0"],"id":"SCV000863590","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN221562","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000735453","record_status":"current","submitter_id":"500086"}
{"submission_id":"506247.2017-08-04","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000587372","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-04","version":"1","trait_set_id":"7920","submission_names":["RMGL-WCRI-05152017"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2014-01-31","assertion_type":"variation to disease","internal_id":"1140299","clinical_assertion_observation_ids":["SCV000587372.0"],"id":"SCV000587372","local_key":"286798|Orphanet:ORPHA145","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"506247"}
{"submission_id":"506497.2018-04-09","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000744620","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACGS Guidelines, 2013\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/3yyso7ro/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf\"}}},\"StudyName\":{\"$\":\"VKGL Data-share Consensus\"}}","date_created":"2018-04-18","version":"1","trait_set_id":"1917","submission_names":["SUB3885264"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-05-31","assertion_type":"variation to disease","internal_id":"1451074","clinical_assertion_observation_ids":["SCV000744620.0"],"id":"SCV000744620","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"506497"}
{"submission_id":"506152.2017-04-19","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000591484","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-25","version":"1","trait_set_id":"7920","submission_names":["SHS20170111"],"date_last_updated":"2020-03-26","assertion_type":"variation to disease","internal_id":"1147928","clinical_assertion_observation_ids":["SCV000591484.0"],"id":"SCV000591484","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:C0677776","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"506152"}
{"submission_id":"505789.2016-12-30","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"In this patient identified as compound heterozygous variants NM_000051.3:c.[497-1G\u003eA];[1236-2A\u003eT].\"}"],"clinical_assertion_trait_set_id":"SCV000494066","review_status":"no assertion criteria provided","variation_archive_id":"VCV000424841","content":"{\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27884168\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-01-26","version":"2","trait_set_id":"770","submission_names":["Ataxia_Telangiectasia"],"date_last_updated":"2020-03-26","assertion_type":"variation to disease","internal_id":"966237","clinical_assertion_observation_ids":["SCV000494066.0"],"id":"SCV000494066","local_key":"NM_000051.3:c.[497-1G\u003eA];[1236-2A\u003eT]|OMIM:208900","interpretation_description":"Uncertain significance","variation_id":"424841","rcv_accession_id":"RCV000416302","record_status":"current","submitter_id":"505789"}
{"submission_id":"506018.2018-05-10","submitted_assembly":"not applicable","interpretation_comments":["{\"text\":\"The p.V292M/R67H/R982C allele was found in trans with p.C634Y in a Chinese family, genotype c.[1901G\u003eA];[200G\u003eA;874G\u003eA;2944C\u003eT]. One family member had both variant RET alleles and MTC onset at 13 yrs. Family members with only the p.C634Y mutation had MEN2A. Family members with the p.V292M/R67H/R982C allele had MTC (70 yr) and C-cell hyperplasia (44 yr). Variants p.R67H and p.R982C are common and likely benign, GnomAD frequency 0.1% and 2%, respectively (gnomad.broadinstitute.org/gene/ENSG00000165731). For reports of p.V292M alone, see c.874G\u003eA.\"}"],"clinical_assertion_trait_set_id":"SCV000788260","review_status":"no assertion criteria provided","variation_archive_id":"VCV000549768","content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21655256\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.arup.utah.edu/database/MEN2/MEN2_display.php\"}}]}}","date_created":"2018-07-27","version":"1","trait_set_id":"8702","submission_names":["MEN2 update May 2018"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-05-04","assertion_type":"variation to disease","internal_id":"1538355","clinical_assertion_observation_ids":["SCV000788260.0"],"id":"SCV000788260","local_key":"6|MedGen:CN073359","interpretation_description":"Pathogenic","variation_id":"549768","rcv_accession_id":"RCV000664336","record_status":"current","submitter_id":"506018"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"In silico models in agreement (deleterious) and/or completely conserved position in appropriate species\"}"],"clinical_assertion_trait_set_id":"SCV000665087","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000481015","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (10/2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/aH4uL7vL/mid-7377_ambry_classification_scheme_oct_2015.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2017-12-28","version":"2","trait_set_id":"13598","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-05-16","assertion_type":"variation to disease","internal_id":"1300505","clinical_assertion_observation_ids":["SCV000665087.0"],"id":"SCV000665087","local_key":"a626669","interpretation_description":"Uncertain significance","variation_id":"481015","rcv_accession_id":"RCV000567707","record_status":"current","submitter_id":"61756"}
{"submission_id":"506864.2019-02-22","submitted_assembly":"GRCh38","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000923905","review_status":"no assertion criteria provided","variation_archive_id":"VCV000481015","date_created":"2019-06-14","version":"1","trait_set_id":"35155","submission_names":["SUB5218044"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-12-01","assertion_type":"variation to disease","internal_id":"1803473","clinical_assertion_observation_ids":["SCV000923905.0"],"id":"SCV000923905","local_key":"NM_000546.5:c.375+5G\u003eA|MeSH:D010051","interpretation_description":"Likely pathogenic","variation_id":"481015","rcv_accession_id":"RCV000785337","record_status":"current","submitter_id":"506864"}
{"submission_id":"506814.2019-11-07","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000925744","review_status":"no assertion provided","variation_archive_id":"VCV000481015","content":"{\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2019-07-03","version":"2","trait_set_id":"9460","submission_names":["SUB6524125"],"date_last_updated":"2020-03-26","assertion_type":"variation to disease","internal_id":"1810638","clinical_assertion_observation_ids":["SCV000925744.0"],"id":"SCV000925744","local_key":"CA645589233","interpretation_description":"not provided","variation_id":"481015","rcv_accession_id":"RCV000786847","record_status":"current","submitter_id":"506814"}
{"submission_id":"505295.2014-08-28","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000190379","review_status":"no assertion criteria provided","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},\"Comment\":{\"$\":\"Variants classified for the Actionable exomic incidental findings in 6503 participants: challenges of variant classification manuscript\"},\"StudyDescription\":{\"$\":\"Variants classified for the Actionable exomic incidental findings in 6503 participants: challenges of variant classification manuscript\"},\"StudyName\":{\"$\":\"ESP 6500 variant annotation\"}}","date_created":"2014-12-04","version":"1","trait_set_id":"2675","submission_names":["ESP 6500 variant annotation"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2014-06-01","assertion_type":"variation to disease","internal_id":"347842","clinical_assertion_observation_ids":["SCV000190379.0"],"id":"SCV000190379","local_key":"UWMG_1586863","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000035406","record_status":"current","submitter_id":"505295"}
{"submission_id":"25969.2019-08-05","submitted_assembly":"not applicable","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant (rs375882485) is a well-known causative variant reported in multiple individuals with hypertrophic cardiomyopathy (HCM; Richard 2003, Maron 2008, Kaski 2012, and Lopez 2013), and shown to segregate with disease in at least one affected family (Camuglia 2013). In one large study, the p.Arg502Trp variant was identified in 2.4% of Caucasian HCM patients (Saltzman 2010). This variant was also found at 1.4% in 6179 individuals diagnosed with HCM (Walsh 2017). Nuclear magnetic resonance studies indicate that p.Arg502Trp may impair important electrostatic interactions between MYBPC3 protein and other sarcomeric proteins (Zhang 2014). Thus, the p.Arg502Trp variant meets our criteria for classification as pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000604327","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","date_created":"2017-09-27","version":"3","trait_set_id":"9590","submission_names":["Aug 2019 ARUP"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-04-07","assertion_type":"variation to disease","internal_id":"1168023","clinical_assertion_observation_ids":["SCV000604327.0"],"id":"SCV000604327","local_key":"118047|MedGen:CN169374","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV001000015","record_status":"current","submitter_id":"25969"}
{"submission_id":"506185.2017-08-22","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.\"}"],"clinical_assertion_trait_set_id":"SCV000606931","review_status":"no assertion provided","variation_archive_id":"VCV000042540","content":"{\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2017-10-13","version":"1","trait_set_id":"17368","submission_names":["GenomeConnect_hg19_81817"],"date_last_updated":"2020-03-26","assertion_type":"variation to disease","internal_id":"1174093","clinical_assertion_observation_ids":["SCV000606931.0"],"id":"SCV000606931","local_key":"genomeconnect_15537_623","interpretation_description":"not provided","variation_id":"42540","rcv_accession_id":"RCV000203913","record_status":"current","submitter_id":"506185"}
{"submission_id":"505443.2016-05-06","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. MYBPC3 p.Arg502Trp This variant has been reported in at least 37 cases of HCM, with strong segregation data. Richard et al (2003) reported this variant in one individual with HCM in their French cohort. Van Driest et al (2004) observed this variant in an HCM patient who also carried p.Gly5Arg in MYBPC3. Details regarding phase and the severity of phenotype were not reported for this patient However, a comparison of the 10 patients, including this one, with multiple variants to the patients with a single variant revealed that the multiple variant group had, on average, a more severe phenotype. Ingles et al (2005) reported observing this variant in one case of HCM. Saltzman et al (2010) reported p.Arg502Trp in 34 of 1414 (2.4%) unrelated cases of HCM, making it the most common variant in that cohort. Four families had another sarcomere variant and individuals with multiple variants were more likely to have severe clinical outcomes. They noted that ~50% of carriers of p.Arg502Trp had overt disease by age 45. They reported a combined Lod score of 4.04 and noted that the likelihood that the observed cosegregation happened by chance was 1/11,000. The highest number of family members cosegregating HCM and the variant in one individual family was three. Note that this paper includes a pedigree reported online by the Seidman group (pedigree FU). Morita et al (2008) observed the variant in two unrelated children with HCM. In one of those cases and affected parent also had the variant. One of these children also carried p.Ser858Asn in MYBPC3 (phase not reported) Note that these families may have been included in the subsequent report by Saltzman et al. Liu et al (2006) reported a Chinese patient with HCM who carried both p.Arg502Trp and IVS27+12C\u003eT, also in MYBPC3. The arginine at codon 502 is highly conserved across species. This mutation results in a non-conservative amino acid change of a positively charged Arginine residue with a non-polar Tryptophan. In silico analysis with PolyPhen-2 predicts the variant to be probably damaging. Another variant at the same codon has been reported in association with HCM (p.Arg502Gln, which we consider very likely disease causing), as have variants in nearby codons (p.Arg495Gln, p.Lys505del, p.Gly507Arg). In total the variant has not been seen in ~395 published controls, including 100 (Richard et al 2003), 200 (van Driest et al 2004), 95 (Saltzman et al 2010). The variant was observed in 1 of 3472 Caucasians and 0 of 1826 African Americans in the NHLBI Exome Sequence Project dataset (as of 7/8/2014). Individual phenotypes from that dataset are not available. Several different cohorts from studies on common complex cardiovascular disease were pooled to create that sample. There is no variant at codon 502 listed in dbSNP or 1000 genomes (as of 7/8/2014).\"}"],"clinical_assertion_trait_set_id":"SCV000280214","review_status":"no assertion criteria provided","variation_archive_id":"VCV000042540","date_created":"2016-06-01","version":"1","trait_set_id":"9460","submission_names":["5_6_2016"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2014-07-08","assertion_type":"variation to disease","internal_id":"528700","clinical_assertion_observation_ids":["SCV000280214.0"],"id":"SCV000280214","local_key":"NM_000256.3:c.1504C\u003eT|Not provided","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000223898","record_status":"current","submitter_id":"505443"}
{"submission_id":"505530.2020-03-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000803346","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"StudyName\":{\"$\":\"AGHI_GT\"}}","date_created":"2018-08-10","version":"3","trait_set_id":"2365","submission_names":["SUB6906800"],"date_last_updated":"2020-03-29","interpretation_date_last_evaluated":"2019-12-30","assertion_type":"variation to disease","internal_id":"1566231","clinical_assertion_observation_ids":["SCV000803346.0","SCV000803346.1","SCV000803346.2","SCV000803346.3","SCV000803346.4"],"id":"SCV000803346","local_key":"11:47364249:G","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000677196","record_status":"current","submitter_id":"505530"}
{"submission_id":"26957.2019-01-29","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The R502W pathogenic variant in the MYBPC3 gene has been reported multiple times in association with HCM (Richard et al., 2003; Van Driest et al., 2004; Ingles et al., 2005; Saltzman et al., 2010; Page et al., 2012; Lopes et al., 2013). This variant has also been observed in multiple unrelated individuals tested for HCM at GeneDx. Richard et al. (2003) identified the R502W variant in one patient with HCM and it was not present in 200 control chromosomes. This study also considered R502 a hot spot\\\" for pathogenic variants because another variant affecting the same residue (R502Q) has also been associated with HCM (Richard et al., 2003; Niimura et al., 1998). Ingles et al. (2005) and Van Driest et al. (2004) observed the R502W variant in one HCM patient each, and the latter publication indicated R502W was not observed in 400 normal control alleles. Page et al. (2012) identified the R502W variant in nine families with HCM, in which variable penetrance and expressivity was observed. This pathogenic variant is observed at a low frequency in large population cohorts, reported in 13/126,700 (0.01%) alleles from individuals of European (non-Finnish) ancestry (Lek et al., 2016). R502W results in a non-conservative amino acid change of a positively charged Arginine residue with a non-polar Tryptophan residue at a position that is highly conserved across species. Functional studies by Zhang et al. (2014) suggested that R502W alters the electrostatic properties of the C3 domain which may disrupt the interaction with other sarcomeric proteins.\\\"\"}"],"clinical_assertion_trait_set_id":"SCV000208031","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2015-02-19","version":"11","trait_set_id":"9460","submission_names":["SUB5098196"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-12-31","assertion_type":"variation to disease","internal_id":"373680","clinical_assertion_observation_ids":["SCV000208031.0"],"id":"SCV000208031","local_key":"GDX:41434|Not Provided","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000223898","record_status":"current","submitter_id":"26957"}
{"submission_id":"1012.2017-08-17","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000614141","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25637381\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23299917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24055113\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22589294\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}}]}}","date_created":"2017-12-14","version":"1","trait_set_id":"9460","submission_names":["SUB2963629"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-12-16","assertion_type":"variation to disease","internal_id":"1197795","clinical_assertion_observation_ids":["SCV000614141.0"],"id":"SCV000614141","local_key":"NM_000256.3:c.1504C\u003eT|not provided","interpretation_description":"Likely pathogenic","variation_id":"42540","rcv_accession_id":"RCV000223898","record_status":"current","submitter_id":"1012"}
{"submission_id":"500199.2018-06-14","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This c.1504C\u003eT (p.Arg502Trp) variant has been reported in multiple patients with hypertrophic cardiomyopathy (HCM) [PMID 1270723, 22589294, 23396983, 20378854, 23642604]. The variant was detected in 34 individuals from a large study of 1,414 unrelated HCM patients [PMID 20378854]. From this study, it was estimated that this variant conveys a 340-fold increased risk for HCM by 45 years and the clinical prognosis worsens when this c.1504C\u003eT (p.Arg502Trp) change occurs in the setting of a pathogenic variant in another sarcomere protein gene [PMID 20378854]. This variant is common among HCM patients, occurring in an estimated 2.4% of patients [PMID 20378854]. This variant was reported in 3 heterozygous individuals in the ExAC database (http://exac.broadinstitute.org/variant/11-47364249-G-A). Arginine at position 502 of the MYBPC3 protein is highly conserved in mammals. While not validated for clinical use, computer-based algorithms predict this p.Arg502Trp change to be deleterious. This variant is thus classified as pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000840016","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-10-11","version":"1","trait_set_id":"2365","submission_names":["SUB4151980"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-05-11","assertion_type":"variation to disease","internal_id":"1637569","clinical_assertion_observation_ids":["SCV000840016.0"],"id":"SCV000840016","local_key":"NM_000256.3:c.1504C\u003eT|OMIM:115197","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000677196","record_status":"current","submitter_id":"500199"}
{"submission_id":"21766.2019-03-21","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant in MYBPC3 has been well reported in many individuals acr oss multiple studies and is known to be pathogenic for hypertrophic cardiomyopat hy (HCM). It is also the most common pathogenic HCM variant identified by our la boratory. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant HCM based upon multiple reports in affected individuals and extensive segregation studies (Richard 2003, Van Driest 2004, Carballo 2005, Ingles 2005, Maron 2008, Kaski 2009, Marston 2009, Saltzman 2010). ACMG/AMP cri teria applied: PS4, PP1_Strong.\"}"],"clinical_assertion_trait_set_id":"SCV000059054","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}}]},\"ReplacedList\":{\"Replaced\":{\"@Accession\":\"SCV000198910\",\"@DateChanged\":\"2015-02-23\",\"@Version\":\"1\"}}}","date_created":"2013-03-16","version":"5","trait_set_id":"17368","submission_names":["SUB5348977"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2011-06-16","assertion_type":"variation to disease","internal_id":"100254","clinical_assertion_observation_ids":["SCV000059054.0"],"id":"SCV000059054","local_key":"2991309|Orphanet:ORPHA217569","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000203913","record_status":"current","submitter_id":"21766"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Rarity in general population databases (dbsnp, esp, 1000 genomes);In silico models in agreement (deleterious) and/or completely conserved position in appropriate species;Deficient protein function in appropriate functional assay(s);Other strong data supporting pathogenic classification;Strong segregation with disease (lod \u003e3 = \u003e10 meioses);Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation;Well-characterized mutation at same position\"}"],"clinical_assertion_trait_set_id":"SCV000319017","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24793961\",\"@Source\":\"PubMed\"}}]}}","date_created":"2016-09-29","version":"4","trait_set_id":"32616","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-06-18","assertion_type":"variation to disease","internal_id":"600711","clinical_assertion_observation_ids":["SCV000319017.0"],"id":"SCV000319017","local_key":"a83323","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000252398","record_status":"current","submitter_id":"61756"}
{"submission_id":"505375.2017-12-19","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The MYBPC3 Arg502Trp s a well known cause of HCM, being reported in multiple HCM cases worldwide and segregating with HCM in families (see Ross et al. Circulation CV Genetics, 2017). The variant is present in the Exome Aggregation Consortium dataset (MAF=0.000025; http://exac.broadinstitute.org/). We have identified this variant in 14 HCM families with some segregation data (total of 7 meiosis). Computational tools SIFT, PolyPhen-2 and MutationTaster predict this variant to be deleterious. In summary, based on segregation, extensive reports of HCM cases with the variant and rarity in the general population, we classify MYBPC3 Arg502Trp as \\\"Pathogenic\\\".\"}"],"clinical_assertion_trait_set_id":"SCV000692517","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"Agnes Ginges Centre for Molecular Cardiology criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/djgybgii/mdi-5363_505375_agnesginges_variantassess_clinvar.pdf\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18403758\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23690394\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21839045\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22563033\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24810389\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18761664\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20818890\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27532257\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-02-23","version":"1","trait_set_id":"6411","submission_names":["SUB3353316"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-03-16","assertion_type":"variation to disease","internal_id":"1353547","clinical_assertion_observation_ids":["SCV000692517.0"],"id":"SCV000692517","local_key":"VAR0000100|OMIM:192600","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000584810","record_status":"current","submitter_id":"505375"}
{"submission_id":"500031.2019-03-28","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces arginine with tryptophan at codon 502 of the MYBPC3 protein (p.Arg502Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs375882485, ExAC 0.01%). This variant has been shown to segregate with hypertrophic cardiomyopathy in more than ten families in the literature, and has been observed in many unrelated hypertrophic cardiomyopathy patients across multiple studies (PMID: 12707239, 20378854, 22267749, 23396983). ClinVar contains an entry for this variant (Variation ID: 42540). A different missense substitution at this codon (p.Arg502Gln) has been reported to segregate with disease in families affected with hypertrophic cardiomyopathy (PMID: 9562578, 22386539). This indicates that the Arg502 residue is important for MYBPC3 protein function. For these reasons, this variant has been classified as Pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000260968","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22386539\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9562578\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}}]}}","date_created":"2016-01-29","version":"7","trait_set_id":"17368","submission_names":["SUB5371970"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-12-27","assertion_type":"variation to disease","internal_id":"485953","clinical_assertion_observation_ids":["SCV000260968.0"],"id":"SCV000260968","local_key":"78346|MedGen:C0007194","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000203913","record_status":"current","submitter_id":"500031"}
{"submission_id":"500026.2018-01-25","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant summary: The MYBPC3 c.1504C\u003eT (p.Arg502Trp) variant involves the alteration of a conserved nucleotide. 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 3/122664 control chromosomes at a frequency of 0.0000245, which does not exceed the estimated maximal expected allele frequency of a pathogenic MYBPC3 variant (0.0010005). This variant has been reported in numerous HCM patients, with evidence of co-segregation of variant with disease in some of the families. Structure study predicted the R502W mutation and other HCM-linked mutations found within the same C3 domain, may directly disrupt the interaction of cMyBP-C with other sarcomeric proteins (Zhang_2014). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. It is the most common pathogenic HCM variant identified by our laboratory. Taken together, this variant is classified as pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000696313","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18409188\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15115610\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15166115\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19293840\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18403758\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-03-15","version":"1","trait_set_id":"32616","submission_names":["2016-2017-variants"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-07-26","assertion_type":"variation to disease","internal_id":"1362665","clinical_assertion_observation_ids":["SCV000696313.0"],"id":"SCV000696313","local_key":"NM_000256.3:c.1504C\u003eT|MedGen:CN230736","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000252398","record_status":"current","submitter_id":"500026"}
{"submission_id":"500060.2018-09-19","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000862304","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MYBPC3\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29121657\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-12-11","version":"1","trait_set_id":"9460","submission_names":["SUB4534263"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-07-10","assertion_type":"variation to disease","internal_id":"1679294","clinical_assertion_observation_ids":["SCV000862304.0"],"id":"SCV000862304","local_key":"71108_000000","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000223898","record_status":"current","submitter_id":"500060"}
{"submission_id":"504895.2016-10-18","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000372355","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","version":"2","trait_set_id":"19227","submission_names":["ICSL_2016Q4"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-06-14","assertion_type":"variation to disease","internal_id":"685877","clinical_assertion_observation_ids":["SCV000372355.0"],"id":"SCV000372355","local_key":"786202|Left Ventricular Noncompaction Cardiomyopathy","interpretation_description":"Uncertain significance","variation_id":"42540","rcv_accession_id":"RCV000351173","record_status":"current","submitter_id":"504895"}
{"submission_id":"504895.2016-10-18","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000372356","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","version":"2","trait_set_id":"33381","submission_names":["ICSL_2016Q4"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-06-14","assertion_type":"variation to disease","internal_id":"685878","clinical_assertion_observation_ids":["SCV000372356.0"],"id":"SCV000372356","local_key":"786202|Dilated Cardiomyopathy, Dominant","interpretation_description":"Uncertain significance","variation_id":"42540","rcv_accession_id":"RCV000403323","record_status":"current","submitter_id":"504895"}
{"submission_id":"504895.2019-02-01","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The MYBPC3 c.1504C\u003eT (p.Arg502Trp) missense variant is well documented as a pathogenic variant for hypertrophic cardiomyopathy (HCM). Across a selection of the available literature, the p.Arg502Trp variant has been identified in heterozygous state in at least 44 individuals diagnosed with HCM. Two of the individuals carried another variant in the MYBPC3 gene in a compound heterozygous state with the p.Arg502Trp variant, and another 11 carried an additional variant in either MYBPC3 or another sarcomere gene (Richard et al. 2003; Van Driest et al. 2004; Ingles et al. 2005; Maron et al. 2008; Marston et al. 2009; Saltzman et al. 2010; Kaski et al. 2012; Lopes et al. 2013; Camuglia et al. 2013). The Arg502Trp variant has also been reported in a heterozygous state in three individuals diagnosed with left ventricular noncompaction cardiomyopathy. One of the individuals was the son of a female proband with HCM who also carried the variant in a heterozygous state. The two other individuals were the brother and nephew of another proband with HCM who also carried the variant in a heterozygous state (Camuglia et al. 2013). The p.Arg502Trp variant was absent from 945 controls (Van Driest et al. 2004; Saltzman et al. 2010) and is reported at a frequency of 0.0001026 in the European (non-Finnish) population of the Genome Aggregation Database. The variant has been shown to segregate with disease in multiple families (Saltzman et al. 2010). Based on the collective evidence, the p.Arg502Trp variant is classified as pathogenic for MYBPC3-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.\"}"],"clinical_assertion_trait_set_id":"SCV000372357","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000042540","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification Criteria 09 May 2019\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22589294\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}}]}}","date_created":"2016-12-02","version":"3","trait_set_id":"33478","submission_names":["SUB5118208"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-05-07","assertion_type":"variation to disease","internal_id":"685879","clinical_assertion_observation_ids":["SCV000372357.0"],"id":"SCV000372357","local_key":"792361","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000778104","record_status":"current","submitter_id":"504895"}
